| OrPha Swiss GmbH - Naloxon OrPha, Injektionslösung |
| 56952 | | 01 | | Naloxon OrPha | | Injektionslösung | | V03AB15 | | Naloxon | | 07.06.2004 | | |
|
| Composition |
| naloxoni hydrochloridum anhydricum 0.4 mg ut naloxoni hydrochloridum dihydricum 0.44 mg, natrii chloridum, natrium 3.54 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Naloxone Hydrochloride Anhydre | 0.4 mg/ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum | | | Sodium Chlorure | | | Sodium | 3.54 mg/ml |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 ampoule(s) | DDP | DDP | B | | Oui |
|
